September 12, 2024
TOPLINE: Patients with ocular hypertension who develop primary open-angle glaucoma (POAG) without visual field loss did not experience a decreased vision-related quality of life compared with […]
September 11, 2024
Share on PinterestTikTok’s viral “blackout challenge” (also known as the “choking challenge” can lead to permanent brain damage or death in under five minutes. Sneksy/Getty Images […]
September 11, 2024
Share on PinterestEli Lilly’s once-weekly insulin injection is as effective as daily shots for managing blood sugar in diabetes, new data shows. Scott Olson/Getty Images New […]
September 11, 2024
Share on PinterestHollywood legend James Earl Jones, known for his iconic roles in The Lion King and Star Wars, managed living with type 2 diabetes for […]
September 11, 2024
(Reuters) -The U.S. Food and Drug Administration has allowed the expanded use of Johnson & Johnson’s drug, Tremfya, to treat adults with a type of chronic […]
September 11, 2024
The University of Virginia is defending the CEO of its health system and its medical school dean in the wake of a very public call for […]
September 11, 2024
This is the third in a three-part series from Medscape on the impact of AI on drug discovery and development. Part 1 is about AI’s role […]
September 11, 2024
The glucagon-like peptide 1 (GLP-1) receptor agonist liraglutide is the first in its class to show benefits in young children with obesity, according to results from […]
September 11, 2024
The glucagon-like peptide-1 (GLP-1) receptor agonist liraglutide is the first in its class to show benefits in young children with obesity, according to results from the […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482483484485486487488489490491492493494495496497498499500501502503504505506507508509510511512513514515516517518519520521522523524525526527528529530531532533534535536537538539540541542543544545546547548549550551552553554555556557558559560561562563564565566567568569570571572573574575576577578579580581582583584585586587588589590591592593594595596597598599600601602603604605606607608609610611612613614615616617618619620621622623
Next page